Fred Hutch, Seattle Cancer Care Alliance, and UW Medicine Complete Restructure of Partnership

Learn More

Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
12 NEW May 16, 2022
HIV antibody trial results offer 'proof of concept'

HIV antibody trial results offer 'proof of concept'

Outcome of AMP shows feasibility of developing potent antibody combinations to block HIV
Hutch News - March 17, 2021
Biostatisticians draft blueprints for COVID-19 vax trials

Biostatisticians draft blueprints for COVID-19 vax trials

Hutch group applies skills honed during decades of HIV prevention trials to bring about safe and effective vaccines for a new pandemic
Hutch News - February 18, 2021
Tailoring vaccine trial recruitment to individual communities

Tailoring vaccine trial recruitment to individual communities

From the HVTN, Vaccine and Infectious Disease Division
Science Spotlight - October 19, 2020
CoVPN team leads campaign to ensure diversity in COVID-19 vaccine trials

CoVPN team leads campaign to ensure diversity in COVID-19 vaccine trials

Fred Hutch-based experts' extensive media efforts drive conversations and awareness about the importance of inclusive participation
Hutch News - September 29, 2020
Improving HIV clinical trials with mobile technology

Improving HIV clinical trials with mobile technology

From the HIV Vaccine Trials Network, Vaccine and Infectious Disease Division
Science Spotlight - July 15, 2019
Two is better than one

Two is better than one

McElrath Laboratory, Vaccine and Infectious Disease Division
Science Spotlight - November 20, 2017
Predicting a durable immune response

Predicting a durable immune response

From HIV Vaccine Trails Network and Vaccine and Infectious Disease Division
Science Spotlight - March 20, 2017
Last Modified, April 02, 2020